Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$54.1 - $110.08 $185,563 - $377,574
-3,430 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$94.25 - $115.99 $323,277 - $397,845
3,430 New
3,430 $367,000
Q3 2021

Oct 28, 2021

SELL
$80.98 - $109.47 $242,130 - $327,315
-2,990 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$92.08 - $124.48 $275,319 - $372,195
2,990 New
2,990 $335,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.52B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Illinois Municipal Retirement Fund Portfolio

Follow Illinois Municipal Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Illinois Municipal Retirement Fund with notifications on news.